RELVAR ELLIPTA 100 MCG + 25 MCG PÓ INAL OR CT STR X 14 DOSES + BAND
Apresentação · Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva exercida pela Agência Nacional de Vigilância Sanitária (ANVISA) · Brasil
-
Número de registro
1010702990011 -
GGREM
510614060051902 -
Código de barras
7896015528812
O que a fonte publica
- Detentor do registro
- GLAXOSMITHKLINE BRASIL LTDA
- Princípios ativos
- TRIFENATATO DE VILANTEROL;FUROATO DE FLUTICASONA
- Embalagem
- 100 MCG + 25 MCG PÓ INAL OR CT STR X 14 DOSES + BAND
- Tipo de produto
- Novo
- Classe terapêutica
- R3F1 - ANTIASMÁTICOS/DPOC AGONISTAS B2 ASSOCIADOS A CORTICOSTERÓIDES, INALANTES
Nomes pelos quais este registro é encontrado
- RELVAR ELLIPTA 100 MCG + 25 MCG PÓ INAL OR CT STR X 14 DOSES + BAND
- RELVAR ELLIPTA
- TRIFENATATO DE VILANTEROL
- FUROATO DE FLUTICASONA
Dados completos da fonte
{
"name": "RELVAR ELLIPTA 100 MCG + 25 MCG PÓ INAL OR CT STR X 14 DOSES + BAND",
"holder": "GLAXOSMITHKLINE BRASIL LTDA",
"stripe": null,
"barcodes": [
"7896015528812"
],
"confaz87": false,
"currency": "BRL",
"marketed": null,
"ggremCode": "510614060051902",
"useDomain": "unknown",
"capApplies": null,
"icmsExempt": false,
"holderTaxId": "33.247.743/0001-10",
"priceRegime": "Regulado",
"productName": "RELVAR ELLIPTA",
"productType": "Novo",
"hospitalOnly": false,
"presentation": "100 MCG + 25 MCG PÓ INAL OR CT STR X 14 DOSES + BAND",
"sourceStatus": null,
"supplyRegime": null,
"factoryPrices": {
"icms-0": "60.90",
"icms-12": "69.20",
"icms-17": "73.37",
"icms-18": "74.27",
"icms-19": "75.19",
"icms-20": "76.13",
"icms-21": "77.09",
"icms-22": "78.08",
"icms-23": "79.09",
"icms-17.5": "73.82",
"icms-19.5": "75.65",
"icms-20.5": "76.60",
"icms-22.5": "78.58",
"icms-12-alc": "61.79",
"icms-17-alc": "65.51",
"icms-18-alc": "66.31",
"icms-19-alc": "67.13",
"icms-20-alc": "67.97",
"icms-21-alc": "68.83",
"icms-22-alc": "69.71",
"icms-23-alc": "70.62",
"withoutTaxes": "54.37",
"icms-17.5-alc": "65.91",
"icms-19.5-alc": "67.55",
"icms-20.5-alc": "68.40",
"icms-22.5-alc": "70.16"
},
"pisCofinsList": "Negativa",
"substanceText": "TRIFENATATO DE VILANTEROL;FUROATO DE FLUTICASONA",
"targetSpecies": [],
"consumerPrices": {
"icms-0": "81.70",
"icms-12": "92.83",
"icms-17": "98.42",
"icms-18": "99.63",
"icms-19": "100.86",
"icms-20": "102.13",
"icms-21": "103.41",
"icms-22": "104.74",
"icms-23": "106.10",
"icms-17.5": "99.03",
"icms-19.5": "101.48",
"icms-20.5": "102.76",
"icms-22.5": "105.41",
"icms-12-alc": "85.42",
"icms-17-alc": "90.56",
"icms-18-alc": "91.67",
"icms-19-alc": "92.80",
"icms-20-alc": "93.96",
"icms-21-alc": "95.15",
"icms-22-alc": "96.37",
"icms-23-alc": "97.63",
"withoutTaxes": "75.17",
"icms-17.5-alc": "91.12",
"icms-19.5-alc": "93.38",
"icms-20.5-alc": "94.56",
"icms-22.5-alc": "96.99"
},
"invalidBarcodes": [],
"activeSubstances": [
"TRIFENATATO DE VILANTEROL",
"FUROATO DE FLUTICASONA"
],
"therapeuticClass": "R3F1 - ANTIASMÁTICOS/DPOC AGONISTAS B2 ASSOCIADOS A CORTICOSTERÓIDES, INALANTES",
"commercialisation": {
"year": 2025,
"marketed": false
},
"priceAnalysisNote": null,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "br.anvisa.cmed-prices"
},
"patientEligibility": "not-assessed",
"registrationNumber": "1010702990011",
"targetSpeciesStatus": "not-reported",
"administrativeStatus": "unknown",
"prescriptionCategory": "unknown",
"prescriptionRequired": null,
"therapeuticClassCode": "R3F1",
"commercialDestination": null,
"registrationNumberFlag": null
}
Leia este registro a partir do seu próprio software
O mesmo registro, com todos os campos e sua procedência, está a uma requisição de distância. A chave de API é gratuita e funciona imediatamente.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=br" \
--data-urlencode "sourceId=br.anvisa.cmed-prices" \
--data-urlencode "id=br:cmed:presentations:510614060051902"